Evidence map›Paper›PMID 34855026›Full record

ArticleTechniques in coloproctology2022

Extensive suppuration and being overweight are factors associated with the failure of laser treatment for pilonidal disease: lessons from the first French retrospective cohort.

L Spindler, A Alam, N Fathallah, A-L Rentien, M Draullette, E Pommaret, M-L Thierry, A El Mituialy, L Abbes, M Aubert and 4 more

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Techniques in coloproctology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07557589 (Radiofrequency Treatment for Pilonidal Disease), which is not on this map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07557589 narecruitingnot on this mapstarted 2026, after this paper: background citation

Radiofrequency Treatment for Pilonidal Disease : Clinical Investigation on Safety of Use, Efficacy and Patient Satisfaction at 6 Months

TypeinterventionalSponsorCHI MONT DE MARSAN ET PAYS DES SOURCESRan2026 to 2027Enrolled60ConditionsInfected Pilonidal SinusArmsRadiofrequency treatment
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

L SpindlerDepartment of MedicoSurgical Proctology, Groupe Hospitalier Paris Saint-Joseph, Paris, France. lspindler@ghpsj.fr.ORCID http://orcid.org/0000-0002-0217-0631
A AlamDepartment of MedicoSurgical Proctology, Groupe Hospitalier Paris Saint-Joseph, Paris, France.
N FathallahDepartment of MedicoSurgical Proctology, Groupe Hospitalier Paris Saint-Joseph, Paris, France.
A-L RentienDepartment of MedicoSurgical Proctology, Groupe Hospitalier Paris Saint-Joseph, Paris, France.
M DraulletteDepartment of MedicoSurgical Proctology, Groupe Hospitalier Paris Saint-Joseph, Paris, France.
E PommaretDepartment of MedicoSurgical Proctology, Groupe Hospitalier Paris Saint-Joseph, Paris, France.
M-L ThierryDepartment of MedicoSurgical Proctology, Groupe Hospitalier Paris Saint-Joseph, Paris, France.
A El MituialyDepartment of MedicoSurgical Proctology, Groupe Hospitalier Paris Saint-Joseph, Paris, France.
L AbbesDepartment of MedicoSurgical Proctology, Groupe Hospitalier Paris Saint-Joseph, Paris, France.
M AubertDepartment of MedicoSurgical Proctology, Groupe Hospitalier Paris Saint-Joseph, Paris, France.
P BenfredjDepartment of MedicoSurgical Proctology, Groupe Hospitalier Paris Saint-Joseph, Paris, France.
E Safa FarDepartment of MedicoSurgical Proctology, Groupe Hospitalier Paris Saint-Joseph, Paris, France.
H BeaussierDepartment of Clinical Research, Groupe Hospitalier Paris Saint-Joseph, Paris, France.
V de ParadesDepartment of MedicoSurgical Proctology, Groupe Hospitalier Paris Saint-Joseph, Paris, France.
Hôpital Paris Saint-Joseph · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe aim of our study was to assess the efficacy of sinus laser therapy (SiLaT) for the treatment of pilonidal disease.

methodsAll adult patients treated with SiLaT in our department between June 1, 2018, and August 23, 2019, were included in the study. Success was defined as the closure of cutaneous orifices and the absence of discharge or abscesses.

resultsWe included 29 consecutive patients (22 males) with a median age of 32.5 ± 10.5 years. Eight patients had already undergone prior surgery for pilonidal disease. The procedure was performed under spinal (55%) or general (45%) anesthesia. The mean follow-up was 370.3 days (± 165.8 days). We observed 2 primary failures (6.9%) and 7 recurrences (24.1%). Ultimately, 20 patients were considered to have been cured (69%). The mean time to healing was 25 days (± 8.1 days). No serious complications were reported. Usual activities were resumed within a mean of 4.9 days (± 7.2), and 86% of patients reported being "very satisfied" with the treatment. The body mass index was lower for patients who were cured (24.0 ± 3.6) than for those who experienced treatment failure (27.6 ± 3.4; p = 0.018). The cured patients were less likely to have one or more secondary openings (35.0 versus 88.9%, p = 0.014).

conclusionsAlmost 70% of our patients were cured by SiLaT. Complications were rare and mild. The technique appeared to be less effective for overweight patients and those with one or more secondary openings associated with pilonidal pits.

Indexed as

OverweightPilonidal SinusAdultHumansLasersMaleRecurrenceRetrospective StudiesSuppurationTreatment OutcomeYoung AdultMinimally invasive techniquePilonidal diseaseSinus laser therapy

Identifiers

PMID34855026
OpenAlexW3217346520

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.